Skip to main content
Top
Published in: Virchows Archiv 2/2021

Open Access 01-08-2021 | Esophagitis | Original Article

Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor

Authors: Minna Nortunen, Nina Väkiparta, Katja Porvari, Juha Saarnio, Tuomo J Karttunen, Heikki Huhta

Published in: Virchows Archiv | Issue 2/2021

Login to get access

Abstract

The pathogenesis of gastroesophageal reflux disease (GERD) is not fully understood. It involves the activation of mucosal immune-mediated and inflammatory responses. Toll-like receptors (TLR) 2 and TLR4 are pattern-recognition receptors of the innate immune system; they recognize microbial and endogenous ligands. Farnesoid X receptor (FXR) is a bile acid receptor that regulates the inflammatory response. We aimed to evaluate TLR2, TLR4 and FXR expression patterns in GERD. We re-evaluated 84 oesophageal biopsy samples according to the global severity (GS) score, including 26 cases with histologically normal oesophagus, 28 with histologically mild oesophagitis and 30 with severe oesophagitis. We used immunohistochemistry and in situ hybridization to assess the expression patterns of TLR2, TLR4 and FXR in oesophageal squamous cells. Immunohistochemistry showed that nuclear and cytoplasmic TLR2 was expressed predominantly in the basal layer of normal oesophageal epithelium. In oesophagitis, TLR2 expression increased throughout the epithelium, and the superficial expression was significantly more intensive compared to normal epithelium, p <0.01. Nuclear and cytoplasmic TLR4 was expressed throughout the thickness of squamous epithelium, with no change in oesophagitis. FXR was expressed in the nuclei of squamous cells, and the intensity of the expression increased significantly in oesophagitis (p <0.05). FXR expression correlated with basal TLR2. In situ hybridization confirmed the immunohistochemical expression patterns of TLR2 and TLR4. In GERD, TLR2, but not TLR4, expression was upregulated which indicates that innate immunity is activated according to a specific pattern in GERD. FXR expression was increased in GERD and might have a regulatory connection to TLR2.
Appendix
Available only for authorised users
Literature
1.
go back to reference Winkelstein A (1935) Peptic esophagitis: a new clinical entity. JAMA. 104(11):906–909CrossRef Winkelstein A (1935) Peptic esophagitis: a new clinical entity. JAMA. 104(11):906–909CrossRef
2.
go back to reference Ismail-Beigi F, Horton PF, Pope CE 2nd. (1970) Histological consequences of gastroesophageal reflux in man. Gastroenterology. 58(2):163–174CrossRef Ismail-Beigi F, Horton PF, Pope CE 2nd. (1970) Histological consequences of gastroesophageal reflux in man. Gastroenterology. 58(2):163–174CrossRef
3.
go back to reference Fiocca R, Mastracci L, Riddell R, Takubo K, Vieth M, Yerian L, Sharma P, Fernström P, Ruth M (2010) Development of consensus guidelines for the histologic recognition of microscopic esophagitis in patients with gastroesophageal reflux disease: the Esohisto project. Hum Pathol. 41(2):223–231CrossRef Fiocca R, Mastracci L, Riddell R, Takubo K, Vieth M, Yerian L, Sharma P, Fernström P, Ruth M (2010) Development of consensus guidelines for the histologic recognition of microscopic esophagitis in patients with gastroesophageal reflux disease: the Esohisto project. Hum Pathol. 41(2):223–231CrossRef
4.
go back to reference Souza RF, Huo X, Mittal V, Schuler CM, Carmack SW, Zhang X, Yu C, Hormi-Carver K, Genta RM, Spechler SJ (2009) Gastroesophageal reflux may cause esophagitis through a cytokine-mediated mechanism, not by caustic (acid) injury. Gastroenterology. 137(5):1776–1784CrossRef Souza RF, Huo X, Mittal V, Schuler CM, Carmack SW, Zhang X, Yu C, Hormi-Carver K, Genta RM, Spechler SJ (2009) Gastroesophageal reflux may cause esophagitis through a cytokine-mediated mechanism, not by caustic (acid) injury. Gastroenterology. 137(5):1776–1784CrossRef
6.
go back to reference Fang Y, Chen H, Hu Y, Diukic Z, Tevebaugh W, Shaheen NJ, Orlando RC, Hu J, Chen X (2013) Gastroesophageal reflux activates the NF-κB pathway and impairs esophageal barrier function in mice. Am J Physiol Gastrointest Liver Physiol. 305:G58–G65CrossRef Fang Y, Chen H, Hu Y, Diukic Z, Tevebaugh W, Shaheen NJ, Orlando RC, Hu J, Chen X (2013) Gastroesophageal reflux activates the NF-κB pathway and impairs esophageal barrier function in mice. Am J Physiol Gastrointest Liver Physiol. 305:G58–G65CrossRef
7.
go back to reference Rieder F, Biancani P, Harnett K, Yerian L, Falk GW (2010) Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol. 298:G571–G581CrossRef Rieder F, Biancani P, Harnett K, Yerian L, Falk GW (2010) Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol. 298:G571–G581CrossRef
8.
go back to reference Lien E, Ingalls RR (2002) Toll-like receptors. Crit Care Med. 30(1 Suppl):S1–S11CrossRef Lien E, Ingalls RR (2002) Toll-like receptors. Crit Care Med. 30(1 Suppl):S1–S11CrossRef
9.
go back to reference Hug H, Mohajeri M, La Fata G (2018) Regulators of the immune response in the human gut. Nutrients. 10(2):203CrossRef Hug H, Mohajeri M, La Fata G (2018) Regulators of the immune response in the human gut. Nutrients. 10(2):203CrossRef
10.
go back to reference Takeda K, Akira S (2004) TLR signaling pathways. Semin Immunol. 16(1):3–9CrossRef Takeda K, Akira S (2004) TLR signaling pathways. Semin Immunol. 16(1):3–9CrossRef
11.
go back to reference Huhta H, Helminen O, Lehenkari PP, Saarnio J, Karttunen TJ, Kauppila JH (2016) Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett’s esophagus, dysplasia and adenocarcinoma. Oncotarget. 7(17):23658–23667CrossRef Huhta H, Helminen O, Lehenkari PP, Saarnio J, Karttunen TJ, Kauppila JH (2016) Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett’s esophagus, dysplasia and adenocarcinoma. Oncotarget. 7(17):23658–23667CrossRef
12.
go back to reference Ding L, Yang L, Wang Z, Huang W (2015) Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharm Sin B. 5:135–144CrossRef Ding L, Yang L, Wang Z, Huang W (2015) Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharm Sin B. 5:135–144CrossRef
13.
go back to reference Gadaleta RM, van Erpecum KJ, Oldenburg B, Willemsen EC, Renooij W, Murzilli S (2011) Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut 60:463–472CrossRef Gadaleta RM, van Erpecum KJ, Oldenburg B, Willemsen EC, Renooij W, Murzilli S (2011) Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut 60:463–472CrossRef
14.
go back to reference Vavassori P, Mencarelli A, Renga B, Distrutti E, Fiorucci S (2009) The bile acid receptor FXR is a modulator of intestinal innate immunity. J Immunol. 183:6251–6261CrossRef Vavassori P, Mencarelli A, Renga B, Distrutti E, Fiorucci S (2009) The bile acid receptor FXR is a modulator of intestinal innate immunity. J Immunol. 183:6251–6261CrossRef
15.
go back to reference De Gottardi A, Dumonceau JM, Bruttin F, Vonlaufen A, Morard I, Spahr L, Rubbia-Brandt L, Frossard JL, Dinjens WNM, Rabinovitch PS, Hadengue A (2006) Expression of the bile acid receptor FXR in Barrett’s esophagus and enhancement of apoptosis by guggulsterone in vitro. Mol Cancer. 5:48CrossRef De Gottardi A, Dumonceau JM, Bruttin F, Vonlaufen A, Morard I, Spahr L, Rubbia-Brandt L, Frossard JL, Dinjens WNM, Rabinovitch PS, Hadengue A (2006) Expression of the bile acid receptor FXR in Barrett’s esophagus and enhancement of apoptosis by guggulsterone in vitro. Mol Cancer. 5:48CrossRef
16.
go back to reference Lian F, Xing X, Yuan G, Schäfer C, Rauser S, Walch A, Röcken C, Ebeling M, Wright MB, Schmid RM, Ebert MPA, Burgermeister E (2011) Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage. Biochem J. 438:315–323CrossRef Lian F, Xing X, Yuan G, Schäfer C, Rauser S, Walch A, Röcken C, Ebeling M, Wright MB, Schmid RM, Ebert MPA, Burgermeister E (2011) Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage. Biochem J. 438:315–323CrossRef
17.
go back to reference Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP et al (1996) The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 111(1):85–92CrossRef Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP et al (1996) The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 111(1):85–92CrossRef
18.
go back to reference Mastracci L, Spaggiari P, Grillo F, Zentilin P, Dulbecco P, Ceppa P, Baccini P, Mansi C, Savarino V, Fiocca R (2009) Microscopic esophagitis in gastro-esophageal reflux disease: individual lesions, biopsy sampling, and clinical correlations. Virchows Archiv : An International Journal of Pathology 454(1):31–39CrossRef Mastracci L, Spaggiari P, Grillo F, Zentilin P, Dulbecco P, Ceppa P, Baccini P, Mansi C, Savarino V, Fiocca R (2009) Microscopic esophagitis in gastro-esophageal reflux disease: individual lesions, biopsy sampling, and clinical correlations. Virchows Archiv : An International Journal of Pathology 454(1):31–39CrossRef
19.
go back to reference Schneider NI, Plieschnegger W, Geppert M, Wigginghaus B, Hoess GM, Eherer A, Wolf EM, Rehak P, Vieth M, Langner C (2014) Validation study of the esohisto consensus guidelines for the recognition of microscopic esophagitis (histoGERD trial). Human Pathology 45(5):994–1002CrossRef Schneider NI, Plieschnegger W, Geppert M, Wigginghaus B, Hoess GM, Eherer A, Wolf EM, Rehak P, Vieth M, Langner C (2014) Validation study of the esohisto consensus guidelines for the recognition of microscopic esophagitis (histoGERD trial). Human Pathology 45(5):994–1002CrossRef
20.
go back to reference Rubio CA, Ichiya T, Schmidt PT (2017) Lymphocytic oesophagitis, eosinophilic oesophagitis and compound lymphocytic-eosinophilic oesophagitis I: Histological and immunohistochemical findings. Journal of Clinical Pathology 70(3):208–216CrossRef Rubio CA, Ichiya T, Schmidt PT (2017) Lymphocytic oesophagitis, eosinophilic oesophagitis and compound lymphocytic-eosinophilic oesophagitis I: Histological and immunohistochemical findings. Journal of Clinical Pathology 70(3):208–216CrossRef
21.
go back to reference Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N et al (2018) Updated international consensus diagnostic criteria for eosinophilic esophagitis: Proceedings of the AGREE conference. Gastroenterology 155(4):1022–1033.e10CrossRef Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N et al (2018) Updated international consensus diagnostic criteria for eosinophilic esophagitis: Proceedings of the AGREE conference. Gastroenterology 155(4):1022–1033.e10CrossRef
22.
go back to reference Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, Dunne PD et al (2017) QuPath: open source software for digital pathology image analysis. Scientific Reports 7(1):16878–16017CrossRef Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, Dunne PD et al (2017) QuPath: open source software for digital pathology image analysis. Scientific Reports 7(1):16878–16017CrossRef
23.
go back to reference Ey B, Eyking A, Klepak M, Salzman NH, Gothert JR, Runzi M, Schmid KW, Gerken G, Podolsky DK, Cario E (2013) Loss of TLR2 worsens spontaneous colitis in MDR1A deficiency through commensally induced pyroptosis. J Immunol. 190(11):5676–5688CrossRef Ey B, Eyking A, Klepak M, Salzman NH, Gothert JR, Runzi M, Schmid KW, Gerken G, Podolsky DK, Cario E (2013) Loss of TLR2 worsens spontaneous colitis in MDR1A deficiency through commensally induced pyroptosis. J Immunol. 190(11):5676–5688CrossRef
24.
go back to reference Ruffner MA, Song L, Maurer K, Shi L, Carroll MC, Wang JX, Muir AB, Spergel JM, Sullivan KE (2019) Toll-like receptor 2 stimulation augments esophageal barrier integrity. Allergy. 74(12):2449–2460CrossRef Ruffner MA, Song L, Maurer K, Shi L, Carroll MC, Wang JX, Muir AB, Spergel JM, Sullivan KE (2019) Toll-like receptor 2 stimulation augments esophageal barrier integrity. Allergy. 74(12):2449–2460CrossRef
25.
go back to reference Verbeek RE, Siersema PD, Vleggaar FP, Ten Kate FJ, Posthuma G, Souza RF, de Haan J, van Baal JW (2016) Toll-like receptor 2 signalling and the lysosomal machinery in Barrett’s esophagus. J Gastrointestin Liv Dis. 25(3):273–282CrossRef Verbeek RE, Siersema PD, Vleggaar FP, Ten Kate FJ, Posthuma G, Souza RF, de Haan J, van Baal JW (2016) Toll-like receptor 2 signalling and the lysosomal machinery in Barrett’s esophagus. J Gastrointestin Liv Dis. 25(3):273–282CrossRef
26.
go back to reference Verbeek RE, Siersema PD, Ten Kate FJ (2014) Toll-like receptor 4 activation in Barrett’s esophagus results in a strong increase in COX-2 expression. J Gastroenterol. 49:1121–1134CrossRef Verbeek RE, Siersema PD, Ten Kate FJ (2014) Toll-like receptor 4 activation in Barrett’s esophagus results in a strong increase in COX-2 expression. J Gastroenterol. 49:1121–1134CrossRef
27.
go back to reference Kohtz PD, Halpern AL, Eldeiry MA, Hazel K, Kalatardi S, Ao L, Meng X, Reece TB, Fullerton DA, Weyant MJ (2019) Toll-like receptor-4 is a mediator of proliferation in esophageal adenocarcinoma. Ann Thorac Surg. 107(1):233–241CrossRef Kohtz PD, Halpern AL, Eldeiry MA, Hazel K, Kalatardi S, Ao L, Meng X, Reece TB, Fullerton DA, Weyant MJ (2019) Toll-like receptor-4 is a mediator of proliferation in esophageal adenocarcinoma. Ann Thorac Surg. 107(1):233–241CrossRef
28.
go back to reference Arias A, Vicario M, Bernardo D, Olalla JM, Fortea M, Montalban-Arques A, Martínez-Fernández P, González-Castro AM, Mota-Huertas T, Arias-González L, Lucendo AJ (2018 Apr 25) Toll-like receptors-mediated pathways activate inflammatory responses in the esophageal mucosa of adult eosinophilic esophagitis. Clin Transl Gastroenterol. 9(4):147CrossRef Arias A, Vicario M, Bernardo D, Olalla JM, Fortea M, Montalban-Arques A, Martínez-Fernández P, González-Castro AM, Mota-Huertas T, Arias-González L, Lucendo AJ (2018 Apr 25) Toll-like receptors-mediated pathways activate inflammatory responses in the esophageal mucosa of adult eosinophilic esophagitis. Clin Transl Gastroenterol. 9(4):147CrossRef
29.
go back to reference Pei Z, Bini EJ, Yang L, Zhou M, Francois F, Blaser MJ (2004) Bacterial biota in the human distal esophagus. Proc Natl Acad Sci USA. 101:4250–4255CrossRef Pei Z, Bini EJ, Yang L, Zhou M, Francois F, Blaser MJ (2004) Bacterial biota in the human distal esophagus. Proc Natl Acad Sci USA. 101:4250–4255CrossRef
30.
go back to reference Pei Z, Yang L, Peek RM Jr, Levine SM, Pride DT, Blaser MJ (2005) Bacterial biota in reflux esophagitis and Barrett’s esophagus. World J Gastroenterol. 11:7277–7283CrossRef Pei Z, Yang L, Peek RM Jr, Levine SM, Pride DT, Blaser MJ (2005) Bacterial biota in reflux esophagitis and Barrett’s esophagus. World J Gastroenterol. 11:7277–7283CrossRef
31.
go back to reference Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z (2009) Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology. 137:588–597CrossRef Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z (2009) Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology. 137:588–597CrossRef
32.
go back to reference Oliveira-Nascimento L, Massari P, Wetzler LM (2012) The role of TLR2 in infection and immunity. Front. Immunol. 3:79CrossRef Oliveira-Nascimento L, Massari P, Wetzler LM (2012) The role of TLR2 in infection and immunity. Front. Immunol. 3:79CrossRef
33.
go back to reference Branger J, Knapp S, Weijer S, Leemans JC, Pater JM, Speelman P, Florquin S, van der Poll T (2004) Role of toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Immun. 72:788–794CrossRef Branger J, Knapp S, Weijer S, Leemans JC, Pater JM, Speelman P, Florquin S, van der Poll T (2004) Role of toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Immun. 72:788–794CrossRef
36.
go back to reference Cario E, Gerken G, Podolsky DK (2007) Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology. 132(4):1359–1374CrossRef Cario E, Gerken G, Podolsky DK (2007) Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology. 132(4):1359–1374CrossRef
37.
go back to reference Hörmann N, Brandão I, Jäckel S, Ens N, Lillich M, Walter U, Reinhardt C (2014) Gut microbial colonization orchestrates TLR2 expression, signaling and epithelial proliferation in the small intestinal mucosa. PLoS One. 9:e113080CrossRef Hörmann N, Brandão I, Jäckel S, Ens N, Lillich M, Walter U, Reinhardt C (2014) Gut microbial colonization orchestrates TLR2 expression, signaling and epithelial proliferation in the small intestinal mucosa. PLoS One. 9:e113080CrossRef
38.
go back to reference Liu HM, Lee TY, Liao JF (2018) GW4064 attenuates lipopolysaccharide induced hepatic inflammation and apoptosis through inhibition of the toll like receptor 4 mediated p38 mitogen activated protein kinase signaling pathway in mice. Int J Mol Med. 41:1455–1462PubMedPubMedCentral Liu HM, Lee TY, Liao JF (2018) GW4064 attenuates lipopolysaccharide induced hepatic inflammation and apoptosis through inhibition of the toll like receptor 4 mediated p38 mitogen activated protein kinase signaling pathway in mice. Int J Mol Med. 41:1455–1462PubMedPubMedCentral
Metadata
Title
Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor
Authors
Minna Nortunen
Nina Väkiparta
Katja Porvari
Juha Saarnio
Tuomo J Karttunen
Heikki Huhta
Publication date
01-08-2021
Publisher
Springer Berlin Heidelberg
Published in
Virchows Archiv / Issue 2/2021
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-021-03066-w

Other articles of this Issue 2/2021

Virchows Archiv 2/2021 Go to the issue